24.01.2014 • NewsDede WillamsChevronConocoPhillips

San Leon Finds More Polish Shale

In the Lewino-1G2 vertical test well near Gdansk in northern Poland, gas exploration company San Leon Energy said it had found shale gas deposits that would yield up to 400,000 cubic feet per day (about 11,300 cubic metres) of gas, adding that the total could rise to millions of cubic feet per day after further exploration.

The Ireland-based firm, which plans to make an announcement on flow rates within 60 days, said the project was the most commercially advanced in Poland. "We've basically cracked the nut in terms of the recipe, in terms of how to frack," executive chairman Oisin Fanning told the news agency Reuters.

The find brightens the prospects for shale gas in Poland after recent setbacks. Chevron and ConocoPhillips are the only global players still active in the country. According to still unconfirmed reports, Italian energy giant Eni is pulling out.

Fanning said San Leon, which began fracking in Poland in July 2013, had succeeded where others had failed through the use of a ceramic of proppant to keep hydraulic fractures open.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.